文献速递其他结缔组织病

IL-21+ Tfh与Tph细胞在ICOS调控下的独特扩增识别伴有异位生发中心与MALT淋巴瘤的干燥综合征

Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren's syndrome with ectopic germinal centres and MALT lymphoma.
PubMed 文献 · Ann Rheum Dis · 2020-09-22

该研究探索Tfh与Tph细胞在干燥综合征(SS)患者中促进异位淋巴结构(ELS)和B细胞MALT淋巴瘤的相关性。多中心采集唾液腺活检及外周血,通过转录组、流式、免疫荧光和组织培养分析发现,ELS+SS患者Tfh特征、IL-21及ICOS通路显著上调,外周Tfh样细胞扩增并产生IL-21,ICOS阻断可减少IL-21及炎性细胞因子产生。

要点

  • ELS+SS患者唾液腺中Tfh特征、IL-21和ICOS通路基因显著上调。
  • 外周CD4+CXCR5+PD1+ICOS+ Tfh样细胞在ELS+SS中扩增且为IL-21主要来源。
  • ICOS阻断可显著减少唾液腺组织培养中IL-21及IL-6、IL-8、TNF-α产生。

核心结论

  • Tfh和Tph细胞、IL-21及ICOS共刺激通路是SS免疫病理的关键致病因素和潜在治疗靶点。

研究设计与样本

  • 从欧盟四中心采集SS患者唾液腺活检及匹配外周血,进行转录组、流式、免疫荧光、原位杂交及唾液腺器官培养功能实验。

主要发现

  • 唾液腺转录组显示ELS+SS患者中Tfh特征、IL-21和ICOS通路基因上调最显著,腮腺MALT-L的IL-21 mRNA增加400倍。
  • 外周CD4+CXCR5+PD1+ICOS+ Tfh样细胞在ELS+SS患者中显著扩增,是IL-21主要产生者,并与循环IgG及补体C4降低相关。
  • 唾液腺中CD4+CD45RO+ICOS+PD1+细胞选择性浸润ELS+组织,在腮腺MALT-L中异常扩增。
  • ELS+唾液腺和MALT-L腮腺中,CXCR5+CD4+PD1+ICOS+Foxp3- Tfh细胞及独特扩增的CXCR5-CD4+PD1hiICOS+Foxp3- Tph细胞频繁双产生IL-21/干扰素-γ但IL-17表达低。
  • 离体唾液腺器官培养中ICOS阻断显著减少IL-21及炎性细胞因子IL-6、IL-8和TNF-α产生。

临床怎么用

  • 检测外周Tfh样细胞及IL-21/ICOS通路可能有助于识别伴有ELS和MALT淋巴瘤风险的SS患者。
  • 阻断ICOS共刺激通路可能成为SS的潜在治疗策略,但需进一步临床验证。

局限性

  • 原文未明确报告研究样本量及具体统计阈值。
  • ICOS阻断效果仅在离体唾液腺器官培养中验证,尚未在临床治疗中评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To explore the relevance of T-follicular-helper (Tfh) and pathogenic peripheral-helper T-cells (Tph) in promoting ectopic lymphoid structures (ELS) and B-cell mucosa-associated lymphoid tissue (MALT) lymphomas (MALT-L) in Sjögren's syndrome (SS) patients. METHODS: Salivary gland (SG) biopsies with matched peripheral blood were collected from four centres across the European Union. Transcriptomic (microarray and quantitative PCR) analysis, FACS T-cell immunophenotyping with intracellular cytokine detection, multicolor immune-fluorescence microscopy and in situ hybridisation were performed to characterise lesional and circulating Tfh and Tph-cells. SG-organ cultures were used to investigate functionally the blockade of T-cell costimulatory pathways on key proinflammatory cytokine production. RESULTS: Transcriptomic analysis in SG identified Tfh-signature, interleukin-21 (IL-21) and the inducible T-cell co-stimulator (ICOS) costimulatory pathway as the most upregulated genes in ELS+SS patients, with parotid MALT-L displaying a 400-folds increase in IL-21 mRNA. Peripheral CD4+CXC-motif chemokine receptor 5 (CXCR5)+programmed cell death protein 1 (PD1)+ICOS+ Tfh-like cells were significantly expanded in ELS+SS patients, were the main producers of IL-21, and closely correlated with circulating IgG and reduced complement C4. In the SG, lesional CD4+CD45RO+ICOS+PD1+ cells selectively infiltrated ELS+ tissues and were aberrantly expanded in parotid MALT-L. In ELS+SG and MALT-L parotids, conventional CXCR5+CD4+PD1+ICOS+Foxp3- Tfh-cells and a uniquely expanded population of CXCR5-CD4+PD1hiICOS+Foxp3- Tph-cells displayed frequent IL-21/interferon-γ double-production but poor IL-17 expression. Finally, ICOS blockade in ex vivo SG-organ cultures significantly reduced the production of IL-21 and inflammatory cytokines IL-6, IL-8 and tumour necrosis factor-α (TNF-α). CONCLUSIONS: Overall, these findings highlight Tfh and Tph-cells, IL-21 and the ICOS costimulatory pathway as key pathogenic players in SS immunopathology and exploitable therapeutic targets in SS.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Pontarini E, Murray-Brown WJ, Croia C, et al. Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren's syndrome with ectopic germinal centres and MALT lymphoma. Ann Rheum Dis. 2020. PMID: 32963045. doi:10.1136/annrheumdis-2020-217646

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。